anal carcinoma (Cancer)
Information
- Disease name
- anal carcinoma
- Disease ID
- DOID:4908
- Description
- "A anus cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells and is located_in the anus." [url:http\://en.wikipedia.org/wiki/Anal_cancer]
Disease area statistics
Chromosome band
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02816879 | Active, not recruiting | N/A | Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men | August 1, 2013 | June 1, 2025 |
NCT00867464 | Active, not recruiting | Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls | March 30, 2009 | December 31, 2023 | |
NCT04713618 | Active, not recruiting | Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy | January 30, 2021 | December 31, 2026 | |
NCT04505553 | Active, not recruiting | Phase 2 | Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | June 1, 2021 | September 30, 2024 |
NCT04272034 | Active, not recruiting | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors | March 26, 2021 | June 20, 2026 |
NCT04230759 | Active, not recruiting | Phase 2 | Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group | January 7, 2020 | March 31, 2027 |
NCT00423254 | Completed | Phase 1 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | February 2007 | November 2009 |
NCT03469596 | Completed | Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? | April 1, 2017 | December 31, 2017 | |
NCT05438836 | Recruiting | Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | January 1, 2022 | January 1, 2031 | |
NCT05663502 | Recruiting | Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers | May 10, 2023 | August 31, 2035 | |
NCT05787535 | Recruiting | Phase 1 | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | March 21, 2023 | September 2025 |
NCT02628067 | Recruiting | Phase 2 | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | December 18, 2015 | May 4, 2027 |
NCT02408861 | Recruiting | Phase 1 | Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | October 21, 2015 | July 1, 2024 |
NCT04802876 | Recruiting | Phase 2 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors | April 12, 2021 | March 31, 2027 |
NCT03241680 | Unknown status | N/A | Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III) | August 2, 2017 | May 31, 2018 |
NCT02369939 | Unknown status | Phase 3 | Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | December 2014 | April 2021 |
NCT01877135 | Unknown status | Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients | August 2013 | June 2019 |
- Disase is a (Disease Ontology)
- DOID:14110
- Cross Reference ID (Disease Ontology)
- MESH:D001005
- Cross Reference ID (Disease Ontology)
- NCI:C9291
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:187762000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0279637
- Exact Synonym (Disease Ontology)
- Ca anus
- Exact Synonym (Disease Ontology)
- carcinoma of anus